Solidarity Wealth’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Solidarity Wealth’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,866	Closed	-$700K	–	98
2023 Q2	$700K	Hold	6,866	–	–	0.29%	49
2023 Q1	$624K	Buy	+6,866	New	+$403K	0.28%	51

Other funds holding RETA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Solidarity Wealth's RETA Position: Q3 2023 in Review

Solidarity Wealth sold out of Reata Pharmaceuticals, Inc. Class A Common Stock (RETA) in Q3 2023, closing a stake of 6,866 shares — an estimated $700K sold.

Solidarity Wealth first reported a position in RETA in Q1 2023 and held it in 2 quarters. The position peaked at $700K in Q2 2023. 2 funds tracked by Wall St. Rank hold RETA as of Q3 2023.

Solidarity Wealth reported no remaining Reata Pharmaceuticals, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
Solidarity Wealth sold 6,866 Reata Pharmaceuticals, Inc. Class A Common Stock shares in Q3 2023, an estimated $700K.
Solidarity Wealth first reported a position in Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2023 and held it in 2 quarters.
Solidarity Wealth's Reata Pharmaceuticals, Inc. Class A Common Stock position peaked at $700K in Q2 2023.
2 funds tracked by Wall St. Rank held Reata Pharmaceuticals, Inc. Class A Common Stock as of Q3 2023.

Based on Solidarity Wealth's 13F filing for Q3 2023, filed 19 Oct 2023.